Workflow
微电生理: 华泰联合证券有限责任公司关于上海微创电生理医疗科技股份有限公司使用暂时闲置募集资金进行现金管理的核查意见

Core Viewpoint - The company is utilizing temporarily idle raised funds for cash management to enhance fund efficiency while ensuring that it does not affect the normal operation of its investment projects [1][8][12]. Fundraising Basic Information - The company raised a total of RMB 1,069,879,920.88 by issuing 70.6 million shares at a price of RMB 16.51 per share, with the funds received on August 25, 2022 [1][2]. Fund Management Agreements - The company and its subsidiary signed agreements with the sponsor and the bank to establish a special account for the management of raised funds, ensuring proper storage and management [2]. Investment Project Overview - The total investment amount for the projects funded by the raised capital is RMB 101,182.57 million [3]. Previous Cash Management - The company approved the use of up to RMB 75,000 million of temporarily idle funds for cash management, with a validity period of 12 months from the board's approval [3][4]. Current Cash Management Plan - The company plans to use up to RMB 65,000 million of temporarily idle funds for cash management, focusing on high-security and liquid investment products [7][8]. Impact on Daily Operations - The cash management will not affect the company's main business operations and aims to improve the efficiency of fund usage, benefiting the company and its shareholders [8][12]. Decision-Making Process - The board and supervisory board approved the cash management plan, ensuring compliance with relevant laws and regulations [11][12]. Sponsor's Opinion - The sponsor has no objections to the cash management plan, confirming that it complies with regulatory requirements and does not alter the purpose of the raised funds [12][13].